Glaukos Corporation announced that it estimates fourth quarter 2015 net sales will be approximately $20.1 million, representing approximately 42% year-over-year growth.

The company expects its full year 2015 net sales will be approximately $71.5 million, representing approximately 57% year-over-year growth.

The company announced that it expects net sales for 2016 to be in the range of $90 million to $93 million, representing an approximate annual growth rate range of 26% to 30%. The company also announced that it expects 2016 net sales to reflect seasonality patterns generally consistent with U.S. cataract procedure volumes, which are typically softer in the first and third quarters and stronger in the second and fourth quarters of a given year.